🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jane C. Davies

Guy's and St Thomas' NHS Foundation Trust

ORCID: 0000-0003-3506-1199

Also affiliated with Cystic Fibrosis Trust, Harefield Hospital, Royal Brompton Hospital, Lung Institute, St. Thomas Hospital, Imperial College London, Royal College of Paediatrics and Child Health

MedicinePhysics and AstronomyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials”.

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00504-5

N/A

1.5DataRank · unranked

67 citations

Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more

Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions

mBio(2021)10.1128/mbio.01763-21

N/A

0.612DataRank · unranked

58 citations

Aurélie Crabbé, Rolf Kümmerli, John J. LiPuma, Jennifer M. Bomberger, Jane C. Davies +33 more

Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?

Paediatric Respiratory Reviews(2021)10.1016/j.prrv.2021.05.002

N/A

0.584DataRank · unranked

48 citations

K. Dick, Sarah Ollosson, D. Jones, Holly Mattock, Siân Bentley +7 more

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.011

N/A

0.520DataRank · unranked

31 citations

Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies, T. Lee +20 more

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202202-0392oc

N/A

0DataRank · unranked

141 citations

Rossa Brugha, Silvia Gärtner, Julian Legg, Alexander Mœller, Pedro Mondéjar-López +19 more

New concepts in antimicrobial resistance in cystic fibrosis respiratory infections

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.10.005

N/A

0DataRank · unranked

43 citations

Rafael Cantón, Helle Krogh Johansen, Lucas R. Hoffman, Tom Coenye, Pierre-Régis Burgel +2 more

Future therapies for cystic fibrosis

Nature Communications(2023)10.1038/s41467-023-36244-2

N/A

0DataRank · unranked

136 citations

Lorna Allen, S.B. Carr, Gwyneth Davies, D.G. Downey, Marie E. Egan +8 more

Entering the era of highly effective modulator therapies

Pediatric Pulmonology(2021)10.1002/ppul.24968

N/A

0DataRank · unranked

28 citations

Rebecca Dobra, Sandra Scott, Clare Saunders, Jess Matthews, Nicholas J. Simmonds +2 more

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00297-7

N/A

0DataRank · unranked

33 citations

John P. Clancy, Raksha Jain, Scott H. Donaldson, Isabelle Fajac, Christopher H. Goss +21 more

96 Is sputum galactomannan a feasible screening test for Aspergillus infection in children with cystic fibrosis?

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01031-7

N/A

0DataRank · unranked

0 citations

C. Lanfranchi, S. Salehian, Andrew Jones, N. Ramadan, Jane C. Davies +2 more

Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202402-0389ci

N/A

0DataRank · unranked

38 citations

Deepika Polineni, A. Christopher Boyd, Scott H. Donaldson, Deborah R. Gill, Uta Griesenbach +6 more

Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target

European Respiratory Review(2024)10.1183/16000617.0001-2024

N/A

0DataRank · unranked

20 citations

Jane C. Davies, Scott H. Donaldson, Raksha Jain, James D. Chalmers, Michal Shteinberg +1 more

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.015

N/A

0DataRank · unranked

17 citations

Dara Riva, Yair J. Blumenfeld, John F. Engelhardt, Carmen Luna‐Paredes, Carlos Milla +17 more

Potential gene therapies for cystic fibrosis: a plain language summary for non-specialists and the lay community

Future Rare Diseases(2025)10.1080/23995270.2025.2531576

N/A

0DataRank · unranked

0 citations

Jane C. Davies, Alan Boyd, Scott H. Donaldson, Deborah R. Gill, Uta Griesenbach +6 more